Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	30.69	114.04	87.26
Graham Fair Price	-84.71	0.07	0.48
PEG	68921.69	-9.39	0.01
Price/Book	-16.34	4.34	5.19
Price/Cash Flow	179.91	-277.83	99.26
Prices/Earnings	3487.92	959.63	-26.75
Price/Sales	18.08	5.82	4.93
Price/FCF	179.91	-277.83	99.26
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	102.33	0.10	0.05
Operating Margin	21.98	0.03	0.03
ROA	-97.74	< 0.005	-0.01
ROE	-0.05	< 0.005	-97.67
ROIC	-0.06	0.01	-75.10
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.10	3.06	-96.81
Dividends QOQ	-1.00	19517.32	1951729.35
EBIT QOQ	-0.03	-0.13	-336.81
EPS QOQ	-19.67	1.02	-94.80
FCF QOQ	4.35	-1.30	-70.12
Revenue QOQ	-0.11	-0.29	-168.24
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	67.74	133.48	97.04
Days Sales Outstanding (DSO)	55.62	66.97	20.41
Inventory Turnover	1.33	0.67	-49.25
Debt/Capitalization	0.25	0.32	27.93
Quick Ratio	0.76	0.65	-15.09
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	0.46	0.46	0.11
Cash	0.11	0.10	-9.19
Capex	-0.02	< 0.005	60.72
Free Cash Flow	0.02	< 0.005	-70.08
Revenue	0.49	0.35	-29.07
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.62	1.71	5.38
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	15.01	25.17	67.74
Naive Interpretation	Member

06 - Financial Health · Weak

Rating